Kiniksa, Scholar Rock set IPO price ranges

Kiniksa Pharmaceuticals Ltd. (Hamilton, Bermuda) and Scholar Rock Holding Corp. (Cambridge, Mass.) each set price ranges on Monday for their respective NASDAQ IPOs.

Kiniksa now plans to sell 7 million shares at $17 to $19 in an IPO underwritten by Goldman Sachs, J.P. Morgan, JMP Securities and Wedbush PacGrow. At the $18 midpoint, the company would raise $126 million and be valued at $845 million...